GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » EV-to-EBIT

Medicus Pharma (Medicus Pharma) EV-to-EBIT : -4.60 (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medicus Pharma's Enterprise Value is $27.83 Mil. Medicus Pharma's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.05 Mil. Therefore, Medicus Pharma's EV-to-EBIT for today is -4.60.

The historical rank and industry rank for Medicus Pharma's EV-to-EBIT or its related term are showing as below:

MDPLF' s EV-to-EBIT Range Over the Past 10 Years
Min: -10.4   Med: 0   Max: 0
Current: -4.67

MDPLF's EV-to-EBIT is ranked worse than
100% of 669 companies
in the Drug Manufacturers industry
Industry Median: 17.95 vs MDPLF: -4.67

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medicus Pharma's Enterprise Value for the quarter that ended in Dec. 2023 was $0.00 Mil. Medicus Pharma's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.05 Mil. Medicus Pharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was %.


Medicus Pharma EV-to-EBIT Historical Data

The historical data trend for Medicus Pharma's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma EV-to-EBIT Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBIT
- - -3.70

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only - - - - -3.70

Competitive Comparison of Medicus Pharma's EV-to-EBIT

For the Drug Manufacturers - General subindustry, Medicus Pharma's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicus Pharma's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's EV-to-EBIT falls into.



Medicus Pharma EV-to-EBIT Calculation

Medicus Pharma's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=27.833/-6.045
=-4.60

Medicus Pharma's current Enterprise Value is $27.83 Mil.
Medicus Pharma's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Pharma  (OTCPK:MDPLF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medicus Pharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-6.045/0
= %

Medicus Pharma's Enterprise Value for the quarter that ended in Dec. 2023 was $0.00 Mil.
Medicus Pharma's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Pharma EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Pharma (Medicus Pharma) Business Description

Comparable Companies
Traded in Other Exchanges
Address
100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire 10-26-2023